News

New insights could result in changes to the therapeutic strategy to combat Alzheimer’s
26 May 2015
Scientists at VIB, KU Leuven and Janssen Pharmaceutica have demonstrated that the distribution of aggregates through the brain is facilitated by synaptic connections between brain cells.
VIB and Performa Investimentos establish GlobalYeast to deliver superior industrial yeast strains for the bio based economy
21 May 2015
VIB and Performa Investimentos today announced the establishment of GlobalYeast, a new company that will develop and deliver superior industrial yeast strains for bioethanol and the green chemicals industry.
Tara Oceans expedition sheds light on the world of plankton
21 May 2015
Plankton is our most important source of oxygen.
How risky is working at VIB
18 May 2015
Overview of accidents at VIB.
Novel insights in MET-proto-oncogene might lead to optimizing cancer treatment
18 May 2015
The MET-proto-oncogene is involved in the pathogenesis of several tumors and therefore represents an interesting target for future therapies currently tested in dozens of clinical trials.
A step forward in understanding muscle diseases
4 May 2015
Rouslan Efremov, together with his former colleagues from Max Planck, unraveled the structure and mechanism of the ryanodine receptor.
Quickscan scientific publications 1st quarter 2015
27 April 2015
VIB's scientific publications 1st quarter 2015
The genome sequence of the orchid Phalaenopsis equestris
20 April 2015
The lab of Yves Van de Peer (VIB Department of Plant Systems Biology) can add an extra genome paper to its long list.
Cell sorting at VIB
16 April 2015
Cell sorting technology enables rapid separation of large numbers of specific cell populations with high purity, recovery, and yield, starting from single cell suspensions.
ThromboGenics and VIB launch New Oncology Company Oncurious NV to develop TB-403 for Pediatric Brain Tumours
14 April 2015
ThromboGenics NV announces the foundation of Oncurious NV, a new oncology company that will develop TB-403 for the treatment of pediatric brain tumors. VIB will become a shareholder alongside ThromboGenics in this new oncology venture.
Epigenomic changes play an important role during the progression of melanoma
9 April 2015
Researchers at KU Leuven, in Belgium, have zeroed in on what makes cancer cells in melanoma so aggressive. They also succeeded in taming the effect in cell cultures.
Revolutionary new insights into blood vessel formation in cancer
1 April 2015
Peter Carmeliet and Sarah-Maria Fendt (VIB/ KU Leuven) have discovered a new strategy to counteract blood vessel formation, based on their research which indicates that fatty acid breakdown is essential in the creation of new blood vessels.
Have we reached the limits of next-generation sequencing?
30 March 2015
The recent VIB Tools and Technologies Conference ‘Revolutionizing Next-Generation Sequencing’ was the ideal opportunity to ask questons to some leaders in the field.
Bio-marker set forms the basis for new blood test to detect colorectal cancer
27 March 2015
Researchers from VIB and KU Leuven have identified bio-markers that can be incorporated in a new diagnostic test. This should make it possible to detect colorectal cancer in an early stage using a simple blood test.
Bioinformatics Services at VIB - all roads lead to BITS
16 March 2015
BITS plays a central role, building upon its expertise in BioIT training, building upon its expertise in BioIT training, scientific software support, and Research and BioIT data analysis support.

«Prev 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 Next»

Get news updates:

Email updates
Follow us on Twitter
Like us on Facebook
RSS